Skip to Content

Acasti Pharma Inc Class A ACST Stock Quote

| Rating as of

Morningstar‘s Stock Analysis ACST

Valuation
Currency in CAD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics ACST

Company Profile ACST

Business Description

Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all which could help to increase treatment compliance and improve patient outcomes.

Contact
3009 Boulevard de la Concorde East, Suite 102
Laval, QC, H7E 2B5, Canada
T +1 450 687-2262
Industry Biotechnology
Most Recent Earnings Mar 31, 2022
Fiscal Year End Mar 31, 2022
Stock Type
Employees 32